article thumbnail

Eli Lilly’s Metabolic Medicine Takes the Lead in the Race to Develop an Oral GLP-1 Drug

MedCity News

The first Phase 3 results for Eli Lillys daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes. The post Eli Lillys Metabolic Medicine Takes the Lead in the Race to Develop an Oral GLP-1 Drug appeared first on MedCity News.

Medicine 235
article thumbnail

Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug

MedCity News

Soleno Therapeutics Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for this rare disease, a leading cause of childhood obesity.

Leads 227
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Precision Pfizer Drug Leads to ‘Unprecedented’ Survival in Colorectal Cancer, Data at ASCO Show

MedCity News

Pfizer drug Braftovi achieved statistically significant and clinically meaningful improvement in overall survival for colorectal cancer patients in a Phase 3 clinical trial. The post Precision Pfizer Drug Leads to Unprecedented Survival in Colorectal Cancer, Data at ASCO Show appeared first on MedCity News.

Leads 232
article thumbnail

Why MDs Should Not Lead Medical Affairs For Best Results

World of DTC Marketing

Today’s Medical Affairs function is not just about scientific rigor — it’s about strategy, cross-functional communication, data fluency, patient-centricity, and commercial awareness. And too often, an MD leading Medical Affairs brings clinical tunnel vision and an insufficient understanding of how the pharmaceutical industry works.

Leads 191
article thumbnail

In gene therapy race, bluebird leads Vertex in activating treatment centers but trails in patient starts

Fierce Pharma

While Vertex leads in patient starts, bluebird has activated more treatment centers. It’s not an easy question to answer.

Leads 315
article thumbnail

Should Physicians Remind Patients They Can Save Money with GoodRx?

World of DTC Marketing

It’s not uncommon for patients to delay filling prescriptions—not because they don’t believe in the treatment, but because they can’t afford it. But should physicians take the extra step and remind patients that these discount services exist? Physicians are aware of this, but patients often don’t openly admit to struggling financially.

article thumbnail

Private Equity Ownership Leads to Worse Patient Outcomes at Hospitals, Study Shows

MedCity News

Yet another study has been published showing that patients receiving care at PE-owned hospitals experienced a higher rate of hospital-acquired adverse events, like infections and falls, than patients receiving care at hospitals that are not PE-owned.

Patients 312